$ Value
—
Shares
57,239
Price
—
Filed
Mar 13
Insider
Name
Dallara Que
Title
Chief Executive Officer
CIK
0001756652
Roles
Transaction Details
Transaction Date
2026-03-11
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
57,239
Footnotes
In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). | Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). | Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. | Includes shares to be issued in connection with the vesting of one or more restricted stock units. | Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. | Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. | Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. | Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. | Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027.
Filing Info
Dallara Que's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-25 | MMED | F | $78K |
| 2026-03-11 | MMED | A | — |
| 2026-03-11 | MMED | A | — |
| 2026-03-11 | MMED | A | — |
| 2026-03-11 | MMED | A | — |
| 2026-03-11 | MMED | A | — |
| 2026-03-11 | MMED | A | — |
| 2026-03-09 | MMED | A | $0 |
| 2026-03-09 | MMED | A | $0 |
| 2025-05-06 | LSCC | M | $0 |
Other Insiders at MMED (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GROSSMAN D KEITH | — | — | 2026-03-09 |
| EISENBERG GLENN A | — | — | 2026-03-09 |
| Wicks Timothy A | — | — | 2026-03-09 |
| Lofton Kevin E | — | — | 2026-03-09 |
|
Dallara Que
Chief Executive Officer
|
— | — | 2026-03-25 |
|
Gyurci John
See Remarks
|
— | — | 2026-03-11 |
|
Wills Courtney Nelson
See Remarks
|
— | — | 2026-03-11 |
|
Spooner Chad
EVP, Chief Financial Officer
|
— | — | 2026-03-11 |
|
Chandrasena Gillian
See Remarks
|
— | — | 2026-03-11 |
|
Dianaty Ali
See Remarks
|
— | — | 2026-03-11 |